Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Randomized, Open-Label, 2-Arm Parallel Study to Compare the Pharmacokinetics, Safety and Tolerability of AVT02 Administered Subcutaneously Via Prefilled Syringe or Autoinjector in Healthy Adult Volunteers (ALVOPAD PEN)

NCT03983876 is registered in ClinicalTrials.gov with Alvotech Swiss AG as lead sponsor.

NCT NCT03983876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03983876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Randomized, Open-Label, 2-Arm Parallel Study to Compare the Pharmacokinetics, Safety and Tolerability of AVT02 Administered Subcutaneously Via Prefilled Syringe or Autoinjector in Healthy Adult Volunteers (ALVOPAD PEN)
Lead sponsor
Alvotech Swiss AG
Phase
Phase 1
Overall status
Completed
Start date
July 1, 2019
Completion date
December 3, 2019
Enrollment
207 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

phase 1